Novartis Wins UK Entresto Patent Case
Londons High Court ruled in favor of Novartis, upholding the patent and supplementary protection certificate for its blockbuster heart drug Entresto. The decision blocks an intended generic rival by Accord Healthcare from launching in the UK this year.
X24 PerspectiveRelated Assets:
X24 Perspective